197 related articles for article (PubMed ID: 21502824)
1. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
Nylund CM; D'Mello S; Kim MO; Bonkowski E; Däbritz J; Foell D; Meddings J; Trapnell BC; Denson LA
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):542-8. PubMed ID: 21502824
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.
Dykes DM; Towbin AJ; Bonkowski E; Chalk C; Bezold R; Lake K; Kim MO; Heubi JE; Trapnell BC; Podberesky DJ; Denson LA
Inflamm Bowel Dis; 2013 Sep; 19(10):2146-54. PubMed ID: 23893081
[TBL] [Abstract][Full Text] [Related]
4. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.
Jurickova I; Collins MH; Chalk C; Seese A; Bezold R; Lake K; von Allmen D; Frischer JS; Falcone RA; Trapnell BC; Denson LA
Clin Exp Immunol; 2013 Jun; 172(3):455-65. PubMed ID: 23600834
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
[TBL] [Abstract][Full Text] [Related]
6. Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.
Wright SS; Trauernicht A; Bonkowski E; McCall CA; Maier EA; Bezold R; Lake K; Chalk C; Trapnell BC; Kim MO; Kugathasan S; Denson LA
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):767-772. PubMed ID: 29216019
[TBL] [Abstract][Full Text] [Related]
7. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.
Däbritz J; Bonkowski E; Chalk C; Trapnell BC; Langhorst J; Denson LA; Foell D
Am J Gastroenterol; 2013 Dec; 108(12):1901-10. PubMed ID: 24145675
[TBL] [Abstract][Full Text] [Related]
9. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.
D'Mello S; Trauernicht A; Ryan A; Bonkowski E; Willson T; Trapnell BC; Frank SJ; Kugasathan S; Denson LA
Inflamm Bowel Dis; 2012 Feb; 18(2):236-45. PubMed ID: 21337672
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
Däbritz J
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Mortha A; Remark R; Del Valle DM; Chuang LS; Chai Z; Alves I; Azevedo C; Gaifem J; Martin J; Petralia F; Tuballes K; Barcessat V; Tai SL; Huang HH; Laface I; Jerez YA; Boschetti G; Villaverde N; Wang MD; Korie UM; Murray J; Choung RS; Sato T; Laird RM; Plevy S; Rahman A; Torres J; Porter C; Riddle MS; Kenigsberg E; Pinho SS; Cho JH; Merad M; Colombel JF; Gnjatic S
Gastroenterology; 2022 Sep; 163(3):659-670. PubMed ID: 35623454
[TBL] [Abstract][Full Text] [Related]
13. High Levels of Anti-GM-CSF Antibodies in Deep Infiltrating Endometriosis.
Toullec L; Batteux F; Santulli P; Chouzenoux S; Jeljeli M; Belmondo T; Hue S; Chapron C
Reprod Sci; 2020 Jan; 27(1):211-217. PubMed ID: 32046390
[TBL] [Abstract][Full Text] [Related]
14. Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
Denson LA; Jurickova I; Karns R; Shaw KA; Cutler DJ; Okou D; Valencia CA; Dodd A; Mondal K; Aronow BJ; Haberman Y; Linn A; Price A; Bezold R; Lake K; Jackson K; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery SL; Dubinsky MC; Leleiko NS; Otley AR; Xavier RJ; Stevens C; Daly MJ; Zwick ME; Kugathasan S
Inflamm Bowel Dis; 2019 Feb; 25(3):547-560. PubMed ID: 30124884
[TBL] [Abstract][Full Text] [Related]
15. Intestinal permeability in patients with chemotherapy-induced stomatitis.
Melichar B; Kohout P; Brátová M; Solichová D; Králícková P; Zadák Z
J Cancer Res Clin Oncol; 2001 May; 127(5):314-8. PubMed ID: 11355146
[TBL] [Abstract][Full Text] [Related]
16. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.
Meager A; Wadhwa M; Bird C; Dilger P; Thorpe R; Newsom-Davis J; Willcox N
Immunology; 1999 Jul; 97(3):526-32. PubMed ID: 10447777
[TBL] [Abstract][Full Text] [Related]
17. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.
Agnholt J; Kelsen J; Brandsborg B; Jakobsen NO; Dahlerup JF
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):649-55. PubMed ID: 15201577
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
Hellmich B; Ciaglo A; Schatz H; Coakley G
Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
[TBL] [Abstract][Full Text] [Related]
19. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.
Han X; Gilbert S; Groschwitz K; Hogan S; Jurickova I; Trapnell B; Samson C; Gully J
Gut; 2010 Aug; 59(8):1066-78. PubMed ID: 20584783
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]